TARO - Taro Pharmaceutical EPS misses by $0.11 beats on revenue May, 19 2020 05:33 PM Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical (NYSE:TARO): Q4 GAAP EPS of $1.42 misses by $0.11.More news on: Taro Pharmaceutical Industries Ltd., Earnings news and commentary, Healthcare stocks news, Read more ...